An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy
BACKGROUND & AIMS: Hydroxychloroquine (HCQ) and chloroquine (CQ) are anti-malarial drugs frequently used in the rheumatologic field. They were recently identified as potential therapeutic options for Coronavirus Disease (COVID-19). The present study aims to map and grade the diverse health o...
Main Authors: | Stefano Celotto, Nicola Veronese, Mario Barbagallo, Francesca Ometto, Lee Smith, Shahina Pardhan, Yvonne Barnett, Petre Cristian Ilie, Pınar Soysal, Erik Lagolio, Peter Konstantin Kurotschka, Roberto Tonelli, Jacopo Demurtas |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220325418 |
Similar Items
-
Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review
by: Kavous Shahsavarinia, et al.
Published: (2021-12-01) -
Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2020-12-01) -
Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01) -
Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19
by: Jarir At Thobari
Published: (2021-08-01) -
A Subject Review on a Some Analytical Methods for the Determination of Chloroquine and Hydroxychloroquine Drugs
by: Ali Khalil Mahmood, et al.
Published: (2022-01-01)